|
市場調查報告書
標的化基因導入市場的投資機會
Homing In on Targeted Delivery Investment Opportunities
| 出版商 |
Lux Research |
| 出版日期 |
2011年09月 |
商品編碼 |
225957 |
| 內容資訊 |
英文 Pages: 24 |
| 價格 |
|
|
標的化基因導入市場的投資機會 是由出版商Lux Research在2011年09月所出版的。
這份英文市場調查報告書包含Pages: 24 價格從美金3500起跳。
新技術的導入的確提昇了醫藥品、消費者產品、農業、工業產品的有效成分傳輸，但是，其開發上的初期階段研究、臨床試驗、現地測試、市場發售等，需要大量的資金。不景氣後，出資雖然有復甦，但是企業所出資的交易以全體來說，還是有些微減少。標的化基因導入市場的投資，醫療與醫藥品持續獨占，但個人保養和消費者產品對投資家來說，也存在著新機會。
本報告，調查分析標的化基因導入市場的投資機會，由下列摘要形式闡述。
第1章 報告摘要
第2章 市場狀況
- 標的化基因導入技術提示投資家長期的風險與報酬
- 耐不景氣的醫療部門應用，依然吸引標的化基因導入投資家的關注
- 創投公司（VC）為標的化基因導入投資整體的一部分且減少當中
- VC的投資為醫療上的應用、傳輸裝置、傾向偏好北美企業
- 首次公開發行股票的傳輸開發企業雖不多，但授權和夥伴契約具吸引力
- 結論
第3章 分析
- 標的化基因導入技術的投資家風險與報酬的平衡取決方式各式各樣
- 醫藥領域的內外新需求擴展周邊產業的機會
- 醫藥以外的標的化基因導入技術投資創造未来先進消費者產品的可能性
第4章 展望
Description
Novel technologies promise to improve the delivery of active ingredients in drugs, consumer packaged goods, agriculture, and industrial products, but their developers require large amounts of capital for early-stage research, clinical or field trials, and market launch. Funding is bouncing back from recession, with $3.6 billion invested since 2004, though venture-backed transactions are a declining fraction of the total. Targeted delivery investments in health care and medicine continue to dominate the industry, but new opportunities beckon to investors in personal care and consumer products, as well.
Table of Contents
- Executive Summary
- Landscape
- Targeted Delivery Technologies Offer Investors a Wide Span of Risk and Reward
- Recession-Resistant Applications in Health Care Consistently Attract Targeted Delivery Investors
- VCs Contributed a Small and Declining Part of Total Targeted Delivery Investment
- VC Investments Favored Health Care Applications, Delivery Devices, and North American Companies
- Few Delivery Developers IPO, but Licensing and Partnering Deals Offer Attractive Exits
- Landscape Conclusions
- Analysis
- Targeted Delivery Technology's Various Investors Balance Risk and Reward Differently
- Targeted Delivery Technology Developers Present a Variety of Risk and Reward Profiles
- New Needs In and Outside Medicine are Opening up Opportunities in Adjacent Industries
- Outside Medicine, Investments in Targeted Delivery Will Enable Tomorrow's Advanced Consumer Products
- Outlook
|
